Neutrophil-to-lymphocyte Ratio Predicts Poor Prognosis in Patients with Chronic Kidney Disease-related Pulmonary Hypertension: A Retrospective Study

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2024 Nov 4

PMID 39496051

Authors

Huipeng Ge

Linlin Zhang

Weiwei Zhang

Qiongjing Yuan

Xiangcheng Xiao

Affiliations

Soon will be listed here.

Abstract

Inflammation plays a crucial role in chronic kidney disease (CKD) and pulmonary hypertension (PH). Considering that the neutrophil-to-lymphocyte ratio (NLR) has recently emerged as a powerful predictor of adverse outcomes in many chronic diseases, we aimed to investigate the association between NLR and all-cause mortality in patients with CKD-related PH. A total of 176 hospitalized patients with predialysis CKD-related PH were recruited retrospectively from January 2012 to June 2020 by reviewing electronic medical records. The NLR and clinical characteristics of the patients were included in the current analysis. The Kaplan-Meier method and univariate and multivariate Cox regression analyses were performed to identify the association between NLR and the incidence of all-cause mortality. Baseline NLR values were associated with hemoglobin, estimated glomerular filtration rate and C-reactive protein. During a median follow-up period of 32.5 (11.3-53.0) months, 23 patients died. Regardless of whether the NLR acted as a continuous variable with a hazard ratio of 1.408 (95% confidence interval: 1.124-1.763) or a categorical variable (NLR ≤4.3 vs NLR >4.3) with a hazard ratio of 3.100 (95% confidence interval: 1.299-7.402), an elevated NLR was significantly associated with all-cause mortality in different models. A greater NLR at baseline was remarkably associated with a higher all-cause mortality in hospitalized patients with CKD-related PH.

References

Djordjevic D, Rondovic G, Surbatovic M, Stanojevic I, Udovicic I, Andjelic T . Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of.... Mediators Inflamm. 2018; 2018:3758068. PMC: 6079471. DOI: 10.1155/2018/3758068. View

Korkmaz C, Demircioglu S . The Association of Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios and Hematological Parameters with Diagnosis, Stages, Extrapulmonary Involvement, Pulmonary Hypertension, Response to Treatment, and Prognosis in Patients with Sarcoidosis. Can Respir J. 2020; 2020:1696450. PMC: 7555456. DOI: 10.1155/2020/1696450. View

Tuder R, Archer S, Dorfmuller P, Erzurum S, Guignabert C, Michelakis E . Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am Coll Cardiol. 2013; 62(25 Suppl):D4-12. PMC: 3970402. DOI: 10.1016/j.jacc.2013.10.025. View

Quarck R, Nawrot T, Meyns B, Delcroix M . C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol. 2009; 53(14):1211-8. DOI: 10.1016/j.jacc.2008.12.038. View

Zhang Q, Wang L, Zeng H, Lv Y, Huang Y . Epidemiology and risk factors in CKD patients with pulmonary hypertension: a retrospective study. BMC Nephrol. 2018; 19(1):70. PMC: 5859392. DOI: 10.1186/s12882-018-0866-9. View

Mathew R . Inflammation and pulmonary hypertension. Cardiol Rev. 2010; 18(2):67-72. DOI: 10.1097/CRD.0b013e3181cd612f. View

Cobo G, Lindholm B, Stenvinkel P . Chronic inflammation in end-stage renal disease and dialysis. Nephrol Dial Transplant. 2018; 33(suppl_3):iii35-iii40. PMC: 6168801. DOI: 10.1093/ndt/gfy175. View

Callejo M, Barbera J, Duarte J, Perez-Vizcaino F . Impact of Nutrition on Pulmonary Arterial Hypertension. Nutrients. 2020; 12(1). PMC: 7019983. DOI: 10.3390/nu12010169. View

Walther C, Nambi V, Hanania N, Navaneethan S . Diagnosis and Management of Pulmonary Hypertension in Patients With CKD. Am J Kidney Dis. 2020; 75(6):935-945. PMC: 7247937. DOI: 10.1053/j.ajkd.2019.12.005. View

10.

Yin X, Xin M, Ding S, Gao F, Wu F, Wang J . Predictive role of perioperative neutrophil to lymphocyte ratio in pediatric congenital heart disease associated with pulmonary arterial hypertension. BMC Surg. 2021; 21(1):3. PMC: 7780205. DOI: 10.1186/s12893-020-01009-x. View

11.

Ikizler T, Cano N, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K . Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013; 84(6):1096-107. DOI: 10.1038/ki.2013.147. View

12.

Tang M, Batty J, Lin C, Fan X, Chan K, Kalim S . Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2018; 72(1):75-83. DOI: 10.1053/j.ajkd.2017.11.018. View

13.

Prins K, Archer S, Pritzker M, Rose L, Weir E, Sharma A . Interleukin-6 is independently associated with right ventricular function in pulmonary arterial hypertension. J Heart Lung Transplant. 2017; 37(3):376-384. PMC: 5854490. DOI: 10.1016/j.healun.2017.08.011. View

14.

Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J . Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012; 379(9818):815-22. DOI: 10.1016/S0140-6736(12)60033-6. View

15.

Diaz-Martinez J, Campa A, Delgado-Enciso I, Hain D, George F, Huffman F . The relationship of blood neutrophil-to-lymphocyte ratio with nutrition markers and health outcomes in hemodialysis patients. Int Urol Nephrol. 2019; 51(7):1239-1247. DOI: 10.1007/s11255-019-02166-6. View

16.

Stevens L, Claybon M, Schmid C, Chen J, Horio M, Imai E . Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int. 2010; 79(5):555-62. PMC: 4220293. DOI: 10.1038/ki.2010.462. View

17.

Kaya T, Acikgoz S, Yildirim M, Nalbant A, Altas A, Cinemre H . Association between neutrophil-to-lymphocyte ratio and nutritional status in geriatric patients. J Clin Lab Anal. 2018; 33(1):e22636. PMC: 6430358. DOI: 10.1002/jcla.22636. View

18.

Navaneethan S, Roy J, Tao K, Brecklin C, Chen J, Deo R . Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD. J Am Soc Nephrol. 2015; 27(3):877-86. PMC: 4769189. DOI: 10.1681/ASN.2014111111. View

19.

Imig J, Ryan M . Immune and inflammatory role in renal disease. Compr Physiol. 2013; 3(2):957-76. PMC: 3803162. DOI: 10.1002/cphy.c120028. View

20.

Li Z, Liang X, Liu S, Ye Z, Chen Y, Wang W . Pulmonary hypertension: epidemiology in different CKD stages and its association with cardiovascular morbidity. PLoS One. 2014; 9(12):e114392. PMC: 4272275. DOI: 10.1371/journal.pone.0114392. View